Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIG Regulatory News (IGG)

Share Price Information for IG (IGG)

Share Price is delayed by 15 minutes
Get Live Data
1,842.00    0.00 (0.00%)
Bid:
0.00
Ask:
1,965.00
Spread: 130.00 (7.084%)
Market Cap: £6.09b
IGG Live PriceLast checked at - London Stock Exchange

Intraday IG Share Chart

Statement regarding Chief Executive

29 Aug 2023 07:00

RNS Number : 5433K
IG Group Holdings plc
29 August 2023
 

29 August 2023

LEI No: 2138003A5Q1M7ANOUD76

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO, OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF THAT JURISDICTION

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

FOR IMMEDIATE RELEASE

IG GROUP HOLDINGS PLC

Statement regarding Chief Executive

IG Group Holdings plc (the "Company") announces that following a short period of medical leave, June Felix has agreed with the Board that due to her health situation she will step down from her position as CEO and director of the Company immediately and cease employment with effect from 29th September.

The Board has appointed Russell Reynolds to undertake a comprehensive search process and expects to appoint a permanent CEO in the coming months. In the meantime, Charlie Rozes will continue in his current role as Acting CEO and Chief Financial Officer.

Mike McTighe, Chair of IG Group, commented: "On behalf of the Board, I would like to extend our best wishes to June as she continues her recovery. We thank her for the significant contribution she has made over the past eight years as a board member and especially as Group CEO for almost five years. During her tenure as CEO the company has successfully pursued a strategy to diversify the business while at the same time strengthening its core OTC business resulting in a doubling of the Group's revenue and profit over the period."

June Felix added: "It has been a great privilege to build and lead such a talented, ambitious group of people as the CEO of IG Group for nearly five years. It has been through everyone's collective effort that we have built a stronger, more diverse company. For this, I thank my executive team, all of my colleagues and the Board of IG Group for an unforgettable period."

As previously announced, IG Group will provide a Q1 trading update at 7am BST on 14th September 2023.

Contact information

IG Group Investor Relations

IG Group Press

FTI Consulting

Martin Price

020 7573 0020

 

Simon Wright

020 7573 0099

investors@ig.com

Angela Warburton

020 7633 5382

 

Alayna Francis

020 7633 5395

press@ig.com

Neil Doyle

07771 978 220

 

Katherine Bell

079 7687 0961

iggroup.sc@fticonsulting.com

 

 

About IG

IG Group (LSEG:IGG) is an innovative, global fintech company that delivers dynamic online trading platforms and a robust educational ecosystem to power the pursuit of financial freedom for the ambitious. For nearly 50 years, the Company has evolved its technology, risk management, financial products, and education and content to meet the needs of its retail and institutional clients. IG Group continues to innovate its offering for the new generation of tomorrow's investors through its IG, tastytrade, IG Prime, Spectrum, and DailyFX brands.

Established in 1974, IG Group is a London-headquartered FTSE 250 company offering its clients access to ~19,000 financial markets through its offices spread across Europe, North America, Africa, Asia-Pacific and the Middle East.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRSELFDAEDSEEA
Date   Source Headline
8th Jun 202611:26 amRNSTransaction in Own Shares
1st Jun 20265:36 pmRNSTotal Voting Rights
1st Jun 20261:06 pmRNSTransaction in Own Shares
26th May 202610:33 amRNSTransaction in Own Shares
19th May 20262:31 pmRNSResult of AGM
19th May 20267:00 amRNSAGM trading update
18th May 202610:05 amRNSTransaction in Own Shares
11th May 20269:59 amRNSTransaction in Own Shares
5th May 202610:48 amRNSTransaction in Own Shares
1st May 202612:07 pmRNSTotal Voting Rights
30th Apr 202612:07 pmRNSDirector/PDMR Shareholding
27th Apr 20269:53 amRNSTransaction in Own Shares
20th Apr 202610:25 amRNSTransaction in Own Shares
13th Apr 202612:11 pmRNSTransaction in Own Shares
8th Apr 20261:17 pmRNSNotice of AGM
7th Apr 20261:23 pmRNSTransaction in Own Shares
1st Apr 20264:05 pmRNSTotal Voting Rights
1st Apr 20267:00 amRNSCommencement of new share buyback programme
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSAppointment of Board Chair
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSFY Results to Dec 25 & Trading Update
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSUnaudited calendar year financial information
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSAppointment of Board Chair
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20264:10 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.